Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions by unknown
Glucosylceramide Is Synthesized at the Cytosolic Surface
ofVarious Golgi Subfractions
Dieter Jeckel,* Achim Karrenbauer,* Koert N. J. Burgerg Gerrit vanMeert and Felix Wieland*
* Institut für Biochemie I der Universität Heidelberg, Germany; and fDepartment ofCell Biology, Medical School, University of
Utrecht, The Netherlands
Abstract. In our attempt to assess the topology of
glucosylceramide biosynthesis, we have employed a
truncated ceramide analogue that permeates cell mem-
branes and is converted into water soluble sphingolipid
analogues both in living and in fractionated cells.
Truncated sphingomyelin is synthesized in the lumen
of the Golgi, whereas glucosylceramide is synthesized
at the cytosolic surface of the Golgi as shown by (a)
the insensitivity of truncated sphingomyelin synthesis
and the sensitivity of truncated glucosylceramide syn-
thesis in intact Golgi membranes from rabbit liver to
treatment with protease or the chemical reagent DIDS;
and (b) sensitivity of truncated sphingomyelin export
and insensitivity of truncated glucosylceramide export
to decreased temperature and the presence of GTP-'y-S
T
HE Golgi apparatus is the site ofmodification ofglyco-
proteins as well as of sphingolipid synthesis. Glyco-
proteins and sphingolipids are believed to be trans-
ported in vesicles through the Golgi apparatus and to the
plasma membrane (reviewed in 24, 34). For our understand-
ing of the molecular mechanisms that underlie biosynthesis
and transport of these compounds it is crucial to know the
topology ofthe enzymes involved. A quite detailed concept
has evolved as to the distribution oftrimming and processing
enzymes that act on glycoproteins during their transport
from the proximal via medial to the distal Golgi cisternae
(19), and recently a corresponding concept has been pro-
posed for the synthesis of glycolipids (28, 36). This concept
involves a distribution within the Golgi of glycosyltransfer-
ases corresponding to their function in the course of
glycosphingolipid biosynthesis: "early" glycosyltransferases,
i .e., GlcCer synthase or lactosylceramide synthase, are
thought to be restricted to the "early" (proximal) Golgi,
whereas "late" reactions (i .e., sialytransferases) are located
in the "late" (distal) Golgi. In the literature there has been
a report that suggested the key enzyme of glycosphingolipid
synthesis, UDP-glucose-ceramide: glucosyl transferase, to
be located at the cytosolic side of the Golgi apparatus (11).
However, this suggestion has not been widely accepted prob-
ably due to problems intrinsic to the experiments carried out
in the study. In particular, the investigation of the topology
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in semiintact CHO cells. Moreover, subfractionation
of rat liver Golgi demonstrated that the sphingomyelin
synthase activity was restricted to fractions containing
marker enzymes for the proximal Golgi, whereas the
capacity to synthesize truncated glucosylceramide was
also found in fractions containing distal Golgi markers.
A similar distribution of glucosylceramide synthesizing
activity was observed in the Golgi of the human liver
derived HepG2 cells. The cytosolic orientation of the
reaction in HepG2 cells was confirmed by complete
extractability of newly formed NBD-glucosylceramide
from isolated Golgi membranes or semiintact cells by
serum albumin, whereas NBD-sphingomyelin remained
protected against such extraction.
of the GlcCer product in the intact membranes was ham-
peredby the limited accessibility ofthe sphingolipid to exter-
nally added glucosylceramidase (<50% after 3 h at 37°C,
even in disrupted membranes). Two approaches have been
developed to circumvent this problem. First, a substrate for
sphingomyelin and glycosphingolipid synthesis has been de-
vised that due to a short fluorescent fatty acyl chain can be
"back-exchanged" from a membrane surface to serum albu-
min or liposomes (20). Second, we have developed a cera-
mide the products of which intercalate into the lipid layer
even less firmly. They are strongly amphiphilic and readily
exchange between membrane and aqueous phase in the ab-
sence of any acceptor. With this compound, a ceramide that
is truncated to a length of eight carbon atoms in both hydro-
phobic chains (t-Cer)', we have characterized the site of
sphingomyelin biosynthesis as being the cis-Golgi (15). Pre-
dominant localization of this activity to the cis and medial
cisternae was independently demonstrated by Futerman and
colleagues (12). Moreover, we have used the t-Cer in living
CHO cells to generate t-Sph as a luminal marker for the cis
Golgi, which has allowed us to access the rate of vesicular
flow from this organelle to the plasma membrane (16). Fi-
1. Abbreviations used in this paper: t-Cer, (truncated) C8, C8-Ceramide;
t-Sph, (truncated) C8, C8-sphingomyelin; t-GlcCer, (truncated)C8, C8-glu-
cosylceramide; DIDS, 4,4'-diisothiocyanatostilbene-2,2' disulfonic acid;
SL-O, Streptolysin O.
259nally, in isolated Golgi membranes t-Cer appeared to be a
potentacceptor for glucose from UDP-glucose and for phos-
phorylcholine from phosphatidy1choline (15, 16) and the
resulting truncated sphingolipid analogues were recovered in
the aqueous medium.
In the current study, both our assay systems confirm ear-
lier suggestions (11) that the synthesis of glucosyl ceramide
occurs at the cytosolic side of the Golgi. In addition, evi-
dence is presented that GIcCer synthesis takes place in the
Golgi, where in contrast to Sph-synthesis it is not limited to
cisternae containing proximal Golgi markers.
Materials and Methods
Materials
3H-UDP-galactose (specific activity 47.5 Ci/mmol) and 3H-UDP-N-acetyl-
glucosamine (specific activity 8.3 Ci/mmol) were purchased from NEN-
research products. UDRglucose, UDP-galactose, UDP-N-acetylglucosamine,
and FBS from Boehringer (Mannheim, Germany) and 4,4'-diisothiocyan-
atostilbene-2,2'-disulfonic acid (DIDS) and BSA, fraction V from Sigma
Chemical Co. (St. Louis, MO). Culture media and solutions were obtained
from Gibco (Glasgow, UK), and culture plastics were from Costar (Cam-
bridge, MA). Streptolysin-O was from Wellcome Diagnostics (Dartford,
UK). C8, C8-Ceramide was prepared according to (16). The N-6[7-nitro-
2,1,3-benzoxadiazol-4-yl]aminocaproyl-sphingolipid analogue NBD-Cer
was synthesized as described (35).
Fractionation ofGolgi
Isolation and Subfractionatlon ofGolgi from Liver. Intact Golgi mem-
branes from rabbit liver were isolated according to (31). Partial separation
ofGolgi cisternae from rat liver was performed according to (32). Marker
enzyme assays were conducted according to the literature: esterase and
galactosyltransferase as described by (4) and N-acetylglucosaminylphos-
photransferase as reported by (25). Galactosyltransferase activity was
35-foldenriched comparedwith the starting postnuclear supernatant, t-Sph-
synthase activity was 30-fold enriched, and t-GIcCer synthase activity
39-fold, whereas Esterase activity was decreased to one fourth. The overall
yield of galactosyltransferase in the Golgi enriched fraction was 25%, of
t-Sph-synthase 21%, of t-GIcCer-synthase 27%, and of Esterase <0.2% .
Protein was determined with the Bicinchoninic acid method according
to Zhang and Hailing (37) after precipitation with TCA (final volume 1 ml,
containing 150 hg deoxycholate as a carrier and 80 mg TCA), with BSA
as a standard.
SubfrpcdonadonofGolgifrom HepG2 Cells. The humanhepatoma cell
line HepG2 (clone a16) was cultured as monolayers on plastic dishes in
MEM containing 10% decomplemented FBS (17, 27). For experiments
monolayers were 80% confluent. Fresh culture medium was added 1 d be-
fore the experiment. HepG2 cells were washed with ice-cold homogeniza-
tion buffer (0.25 M sucrose, 1 mM EDTA, 10 mM Hepes, pH 7.4) and
scraped into 750 pl of this buffer with a rubber policeman. Subsequently,
they were passed 15 times through two 30-gauge needles (30G1/2) con-
nected by 100 mm ofpolythene tubing of0.28-mm inner diameter. A post-
nuclear supernatant was prepared by a 10-min spin at 375 g., and the
volume was made 1 ml with homogenization buffer. The homogenate was
loaded on top of a 10.3 ml 0.7 M-1.5 M linear sucrose gradient (containing
1 mM EDTA and 10 mM Hepes, pH 7.4). Gradients were spun for 3 h at
38,000 rpm (250,000 g) in a SW41 rotor (Beckman, Palo Alto, CA), af-
ter which they were harvested into 11 fractions of 1 ml on ice. Fractions
were assayed for enzyme activities immediately, or extracted for lipid
analysis.
%atmentofGolgiwithPronaseorDIDS
Pronase treatment ofmembranes (250,ug protein) (protein/protease = 5:1)
was performed in 50 mM NaCl, 10 mM EDTA in 10 mM Tris/maleate, pH
7.4, in a total volume of 70 td at 37°C for different time intervals. After
incubation the samples werediluted threefold with ice-cold buffer, overlaid
on 1 ml 10 mM Tris/maleate, pH 7.4, containing 500 mM sucrose and 2
mg BSA/ml, and the membranes pelleted by centrifugation (30 min at
170,000 g and 4°C). The pellets were resuspended in 250 mM sucrose in
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10 mM Tris/maleate, pH 7.4, and aliquots used for determination of t-Sph-
and t-GIcCer-synthesis.
DIDS-treatment as described by (30), with the following modifications:
Golgi membranes (50,ug protein) were preincubated with various concen-
trations ofDIDS at 25°C for 10min in 15 pl of50 mM NaCl, 10mM EDTA
in 10 mM Tris/maleate, pH 7.4, before addition of 3H-t-Cer and UDP-
glucose. t-Sph and t-GIcCer-synthesis was followed as described above.
Determination ofSphingomyelinand
Glucosylceramide Synthesis
A standard assay to follow t-Sph and t-GIcCer synthesis in Golgi mem-
branes contained in a total volume of 20 pl 10-50 ag intact Golgi mem-
branes, 100 pM 3H-t-Cer (specific activity 150 kCi/pmol), 50 mM NaCl,
10 mM EDTA, 4 mM UDRglucose in 10 mM Tris/maleate, pH 7.4. This
mixture was incubated undervigorous shaking at 37°C for40 min. Reaction
was stopped by addition of 1 vol i-propanol, centrifuged (10,000 g, 2 min)
and analiquot ofthe mixture analyzed by TLC on Whatman silica gel plates
LK 6 in butanone-2/acetone/water/formic acid = 30/3/5/0.04. The chro-
matograms were evaluated by an automatic TLC-2D-analyzer (digital au-
toradiograph, Berthold, Wildbad, FRG). The yield of the radioactivity de-
termination in the TLC scanner was calculated by correlation to the 3H
countsfound by liquidscintillationcounting: a spot of45,000 counts (counts
per hour) is equivalent to 55,000 cpm and to 125 pmol oft-sphingolipid.
Anassay mixture without UDRglucose led to synthesis oft-Sphexclusively.
Fractions from sucrose density gradients were similarly assayed except
that the final volume ofthe reaction mixture was 12 .5 ~d and the concentra-
tion oft-Cer was 50 AM. With 3.3 x 105 dpm 3H-t-Cer per assay, fractions
with maximal activity incorporated N3 x 10° dpm into t-Sph and (in the
presence of UDP-Glc) -4 x 10° dpm into t-GIcCer.
The synthesis of NBD-Sph and NBD-GIcCer was determined in cell
homogenates or gradient fractions from HepG2 cells by the use of the
fluorescent precursor NBD-Cer (20), in an assay similar to those described
by Constantino-Ceccariní et al. (10) and Futerman et al. (12). To a 250-Al
aliquot from each gradient fraction was added 200 al ofNBD-Cer contain-
ing liposomes (13 nmol C6-NBD-Cer, 13 mol% in unilamellar phospha-
tidylcholine liposomes [35]) and 50 pl UDRglucose (final concentration
500 jAM). The mixture was incubated for 15 min at 37°C, and the reaction
stopped by the addition of 1.6 ml of ice-cold methanol/chloroform (2.2:1,
vol/vol). The fluorescent lipids were extracted according to Bligh and
Digher (8). All aqueous solutions were acidified to 10 mM acetic acid. Flu-
orescent lipids were analyzed by thin layer chromatography in chloro-
form/acetone/methanol/acetic acid/water, 50:20:10:10:5 (vol/vol). Fluores-
cence was quantitated as described before (33). A nonfluorescent cell
extract gave a background value for the GIcCer or Sph spots equivalent to
1 pmol NBD-Sph. In the enzyme assay using NBD-Cer, the total back-
ground ofthe assay mixture without sample was 3 pmol for Sph and 5 pmol
forGIcCer. This amounted to 10and20% ofthe maximal activity measured
on gradients, respectively (t5%; n = 11).
AssayforSidedness ofNBD-Sph and NBD-GIcCer
in Organelles
Incorporation ofNBD-Upids into Intact Cells. HepG2 monolayers were
washedtwice withHBSS without bicarbonate, 10 mM Hepes (4-[2-hydroxy-
ethyl]-1-piperazine ethanesulfonic acid), pH 7.4 (HBSS) . NBD-Cerwas ap-
plied to the cells (13 mol% in unilamellar phosphatidylcholine liposomes,
100 nmol NBD-Cer in 4 ml for 9-cm dishes; (35)) for 1 h at 10°C. Under
theseconditions, the lipid partitionsintothecellular membranes and reaches
the site where it is metabolically converted to NBD-GIcCer and NBD-Sph.
After removal oftheliposomes andtwo washes with HBSS, cells were incu-
bated for 3 h in the presence of 1% (wt/vol) BSA at either 0°, 10°, 15° or
20°C (identical results). The figures representthemeanof4-10experiments.
After removal of the BSA-containing medium and two washes with HBSS,
the cells were homogenized as described above.
AssayforSidedness
To test for the fraction of the NBD-lipids that was luminally located in the
organelles (see Results) each sample was split into two 500-Al fractions. To
the control fraction was added 250 pl of homogenization buffer, and to the
test fraction 250 Al ofa 20% (wt/vol) BSA solution in the samebuffer. The
samples were left on ice for 30 min, after which they were fractionated on
sucrose gradients as described above.
260PermeabilizedCells
Synthesis of t-Sph and t-GIcCer in and Secretion from permeabilized
CHO-15B Cells. Semiintact CHO-15Bcells were prepared by the swelling-
scraping method according to Beckers et al. (6). Incubation of semiintact
cells at low temperature or in the presence of GTP--y-S wascarried out as
described (14). For the determination oft-GIcCer synthesis 500/AM UDP-
glucose was added.
Sidedness of NBD-Sph and NBD-GIcCer in Aermeabilized HepG1
Cells. After washing HepG2 monolayers three times with ice-cold PBS
without Cat+ and MgZ+ streptolysin-O (SL-0) was bound for 10 min at
0°C (0.5 Uin 0.5 ml per 3-cm dish) (2) . Excess SL-0 wasremoved by two
washes with PBS without Cat+ and MgZ+, followed by two additional
washes with transport buffer (80 mM K+-glutamate, 15 mM KCI, 5 mM
NaCl, 0.8 mM CaCIZ, 2MM MgCIZ, 1.6 mM EGTA, 20 mM Hepes/KOH,
pH 7.2). Permeabilization was carried out by raising the temperature to
37°C for 10 min. After this procedure 100% of the cells were stained by
trypan-blue, a stain that cannot permeate intact membranes.
After four washes with transport buffer at 0°C, permeabilized cells were
incubated in 1 ml of the buffer containing 1 mM UDRglucose, an energy-
regenerating system(0.5 mM ATP, 2mM creatinephosphate, and 114 jig/ml
creatine kinase), and NBD-Cer (concentration as above) for 3 hat 12°C.
Under these conditions synthesis of NBD-lipids in permeabilized cells was
comparable to that in intact cells. Subsequently, the medium was replaced
by 1 ml of 3 % (wt/vol) BSAin transport buffer and the depletionof cellular
NBD-lipids into the BSA-medium wasfollowed in time at 12°C. Acontrol
experiment showed that during depletion for 3.5 h, only little additional
NBD-lipid synthesis had occurred: 4% for GIcCer, 13% for Sph.
Results
t-GlcCerSynthase IsAccessible toProtease
A widely applied method to study the topology ofmembrane
proteins is to assay the sensitivity to digestion with proteases
of the protein under study. We have investigated the influence
ofprotease treatment on the t-GIcCer synthesizing activity of
TIME [min)
Figure 1. GIcCer synthase inintact membranes is accessible to pro-
tease. Intact Golgi membranes were incubated with pronase E at
37°C, and at the time points indicated samples were diluted with
ice-cold buffer (containing an excess of BSA) and centrifuged
through alayer of buffered sucrose solution containing 2mg BSA/
ml. The pellets were resuspended andaliquots used for the deter-
mination of t-Sph-synthase activity (o-o); galactosyltransferase
activity ("-_); andt-GIcCer synthase activity (x-x). Forexperi-
mental details see Materials and Methods.
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rabbit liverGolgi membranes. The effects ofpronase E treat-
ment on the t-GIcCer synthase and the t-Sph synthase activi-
ties (and, as a control, luminal galactosyltransferase) were
followed in time. The results are shown in Fig. 1. After 20
min, t-GIcCer synthase is depressed to <10% of its original
activity, whereas t-Sph synthesis and the activity ofthe lumi-
nal enzyme galactosyltransferase are only slightly affected.
GIcCer Synthase IsInhibitedbya
NonmembranepermeableDrug
DIDS has been used to block various membrane channels
and proteins (11, 30) . The drug covalently binds to basic
amino acid residues and thereby inactivates enzymes in a
quite unspecific manner. It has been shown that the com-
pound is unable to penetrate membranes. If inhibition of an
enzyme is observed after addition of the drug to isolated in-
tact membranes it is likely that the active center of this en-
zyme is localized at the accessible (cytosolic) side of the
membrane. We have incubated intact isolated Golgi mem-
branes with increasing concentrations of DIDS and subse-
quently measured their t-GIcCer as well as t-Sph synthase
activities. The results are shown in Fig. 2. Sphingomyelin
synthase is not affected up to concentrations of 200 UM of
the drug. In contrast, GIcCer synthase activity is decreased
to 50% at a DIDS concentration of -60 AM .
t-GIcCerIsReleasedfrom Semiintact Cellsunder
Conditions Where t-SphIs Retained
Permeabilized (semiintact) (29) cells have been shown to re-
tain the ability to expedite vesicular biosynthetic transport
from the ER to the Golgi (6) and to the plasma membrane
(14). t-Sph has served as a luminal marker for monitoring
the flow of vesicles from the proximal Golgi to the plasma
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Figure 2. Decrease ofGIcCer synthase activity by DIDS, a protein
modifying reagent that cannot pass membranes. Golgi membranes
were incubated with increasing concentration of DIDS for 10 min
at 250C. Thereafter, theactivities oft-GIcCer synthesis (x-x) and
of t-Sph synthesis (moo) were determined as described in Ma-
terials and Methods.membrane in permeabilized as well as in intact CHO cells
(14) . It has been shown that vesicular transport is inhibited
by lowering the temperature (21) as well as by the addition
ofthe nonhydrolyzable GTP analogue GTR,y-S (22, 23, 36).
t-Sph-transport in semiintact cells is vesicular, because it is
inhibited by lowering the temperature to 15°C or by the pres-
ence of GTP--y-S (14). We have investigated the secretion of
t-GlcCer under these conditions. Both markers are secreted
at 37°C (14), whereas at 15°C t-Sph is efficiently retained
(Fig. 3 A) . In contrast, at this temperature t-GlcCer is
released into the medium to an extent indistinguishable from
the 37°C control experiment (Fig. 3 B).
In nonpermeabilized, living cells at 15°C both truncated
sphingolipids, t-Sph and t-GlcCer are retained to about the
same extent (Fig. 3, C and D) .
As shown in Fig. 4, in the presence of GTP-y-S, t-Sph ex-
_
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port is clearly reduced in permeabilized cells at 37°C (Fig.
4 A). In contrast, t-GlcCer secretion is insensitive to this
nucleotide (Fig. 4 B).
Distribution oft-GlcCerSynthase within the Golgi
RatLiverApparatus
The ease with which t-GlcCer synthase can be determined
in isolated intact membranes allowed us to localize the activ-
ity on sucrose density gradients. To this end, rat liver Golgi
was subjected to sucrose gradient fractionation (32) . In Fig.
5, a distribution of enzyme activities is shown that reside in
the ER (3), the proximal Golgi (13), and the distal Golgi
(26). Although no baseline separation was achieved, the
marker enzyme activities reproducibly appear in distinct
peaks (Fig. 5 B), shifted from each other. As shown earlier
û
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Figure 3. t-GlcCer is not retained in semiintactcells at 15°C. CHO 15B cells were permeabilized according to Beckers et al. (6) and aliquots
of the resuspended semiintact cells were incubated with 3H-t-Cer at the temperatures and for the times indicated. 3H-t-Sph and 3H-t-Glc-
Cer were assayed as described in Materials and Methods. o--0 shows the content of the 3H-t-sphingolipid in the media, and o--o shows
that in the semiintact cells (SIC) (A and B). As a control, intact CHO 15B cells were incubated with 3H-t-Cer at 15°C, and 3H-t-sphingo-
lipids determined in the cells (o-o) and media (o- o) (C and D) .U
Q
O t-GIcCer
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Figure 4. GTR.y-S does not inhibit secretion of t-GIcCer in semi-
intact cells at 37°C. CHO 15B cells were permeabilized according
to Beckers et al. (6). The semiintact cells were incubated in the
presence of 100,.M GTR.y-S as described (14), and the individual
3H-t-sphingolipids quantitated in aliquots taken at the time points
indicated. (o-o) media; (c-fl) semiintact cells.
(15), t-Sph synthesis follows the profile ofthe proximal Golgi
marker enzyme N-acetyl-glucosaminylphosphotransferase,
while in studies by Futerman et al. (12) cofractionation of
Sph-synthase was observed with the proximal Golgi marker
mannosidase II. Although t-GIcCer synthase activity is ob-
served along the phosphotransferase peak as well, a second
peak oft-GIcCer synthase is obtained that coincides with that
of galactosyltransferase, a distal Golgi marker (Fig. 5 A).
The protein profile of the gradient is shown in Fig. 5 C. In
four experiments the separation achieved was as shown in
Fig. 5 A, whereas in eight experiments only one instead of
two fractions was present between the proximal and distal
activity peaks. The assays of t-Sph-synthase and t-GIcCer
synthase activities were performed under conditions where
the substrate t-Cer was not limiting as determined by the
amount oft-Cer left in each incubation after the assay, which
was in excess and therefore aboutthe same in each fraction .
To exclude that these findings are specific to the cells and
the assay system used, we have extended this study by the ap-
plication ofan established marker for sphingolipid synthesis,
NBD-Ceramide (20), to another established liver cell sys-
tem, the human hepatoma HepG2. HepG2 cells were in-
cubated with NBD-Cer, and after breaking the cells the
distribution of the NBD-lipid-derivatives along a sucrose
density gradient was determined in the presence or absence
of scavenger BSA in the homogenization buffer. Lipids in the
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Figure 5. Partial separation of t-GIcCer- and t-Sph synthase activi-
ties in rat liver Golgi. Rat liver Golgi membranes were submitted
to sucrose density gradient centrifugation as described (32), and
3H-t-Sph (emu) and 3H-t-GIcCer synthase (o-o) activities
were assayed (A). The gradient was characterized by measuring
the activities of marker enzymes for the ER (Esterase; ref. 4)
(moo) for the proximal Golgi (G1cNAc-phosphotransferase; ref.
25) (w_a) and for the distal Golgi (galactosyltransferase; ref. 4)
(o- o) (B). In C the protein content (&--o) and the sucrose con-
centration of the fractions (o-o) are shown.
outer leaflet of an organelle that come into contact with BSA
will bind to the protein and therefore stay with the soluble
protein fraction on top of the gradient, whereas lipids in the
inner leaflet of a membrane are protected against depletion
by the BSA and will migrate with the membrane fraction.
Fig. 6 shows the gradient profiles obtained. In Fig. 6 A the
distribution of free NBD-Cer is givenin the presence or ab-
sence of BSA. In the absence of the scavenger protein, the
bulk amount of NBD-Cer migrates to the position where
most of the membranes are, i.e., about two thirds down the
gradient. In contrast, in the presence of BSA most of the
NBD-Cer is found on top of the gradient. Fig. 6, B and C
shows the distribution of the GIcCer- and Sph-derivatives,
respectively. Most of the GIcCer analogue runs with the bulk
of the membranes and is accessible to BSA, whereas thew
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Figure 6. Sidedness of NBD-sphingolipids in HepG2 cells. HepG2
cells were incubated with NBD-Cer and homogenized. The frac-
tion of the newly synthesized NBD-sphingolipids present on the
cytoplasmic surface ofthe Golgi was quantitated by assaying its ac-
cessibility to the scavenger protein BSA. The postnuclear superna-
tant was incubated in the presence or absence of BSA for 30 min
at 0°C, and then fractionated on a sucrose gradient. The individual
NBD-lipids in each fraction were quantitated. (o-o) No scaven-
ger protein added; (f-*) BSA added to the homogenization
buffer.
main fraction of the Sph-derivative migrates with the mem-
branes to the Golgi area of the gradient both in the presence
and absence of BSA. These findings indicate that the NBD-
Sph is located at the inner, lumenal leaflet and NBD-G1cCer
at the outer, cytosolic leaflet ofthe membranes, in full accor-
dance with the results obtained in CHO cells with the trun-
cated sphingolipid analogues. The sidedness of G1cCer
versus Sph was assayed in an additional experiment in per-
meabilizedHepG2 cells, as shown in Fig. 7. After treatment
with streptolysin-O, HepG2 cells were incubated with NBD-
Cer at 12°C for 3 h. Thereafter, the ceramide-containing
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Figure 7 . NBD-Cer is not retained in semiintact cells at 12°C.
HepG2 cells werepermeabilized with streptolysin O, and incubated
with NBD-Cer for 3 h at 12°C to allow for NBD-sphingolipid syn-
thesis. Starting at t = 0, at each timepointthe medium was replaced
by a buffer containing 3% BSA. NBD-lipids in media and cells
were assayed as described under Materials and Methods. (0-0)
shows the content of NBD-lipids in the media; (o--o) shows that
in the semiintactcells (SIC). Each curve representsthe mean oftwo
experiments, with deviations less than the symbol size.
medium was replaced by a medium containing BSA as a
scavenger. More than 85% of the NBD-G1cCer was recov-
ered in the BSA-containing medium, whereas only 20% of
the NBD-Sph was accessible to the scavenger.
The distribution of sphingomyelin synthase and UDP-
glucoselceramide glucosyltransferase activities (as assayed
with NBD-Cer) alonga sucrose density gradient afterappli-
cation of a total postnuclear supernatant is shown in Fig. 8.
Both sphingolipid activities are clearly separated from the
maximum of the ER marker and, like in subfractionated rat
liver Golgi (see Fig. 5 A), G1cCer synthase shows two max-
ima whereas Sph synthase runs essentially in a single peak.
Both the protease digestion and the protein modification ex-
periments shown here confirm earlier findings by Coste et
al. (11), and suggest a cytosolic orientation of the GlcCer
synthase enzyme. However, neither type of experiment ex-
cludes the possibility that the active site of the enzyme is lu-U
Q
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Figure 8. NBD-Sph- and NBD-GlcCer synthase activities in Golgi
membrane fractions after separation by sucrose density gradient
centrifugation. HepG2-postnuclear supernatant was subjected to
sucrose density gradient centrifugation as described in Materials
and Methods. Esterase activity was determined as an ER-marker.
The fractions with maximal esterase activities are indicated with
arrows. Sph- (F~) and GlcCer synthase (0--0) activities were
determined by an NBD-Cer assay as described in Materials and
Methods.
minal, and that the enzyme is inhibited by nicks or covalent
modifications introduced into its cytosolic moiety by pro-
tease or protein modification reagents, respectively. There-
fore, we have investigated the topology of sphingolipid bio-
synthesis in experiments that do not aim to modify the
enzymes involved but rather to quantitate the amount of
sphingolipids produced at either side ofthe Golgi membrane
system. This couldbe achieved on the one hand by combin-
ing semiintact CHO cells with the truncated ceramide that
gives rise to watersoluble truncated sphingomyelin and glu-
cosyl ceramide, and on the other hand by the use of perme-
abilized or homogenized HepG2 cells combined with short
chainNBD-sphingolipids that can be "back-exchanged" from
membrane surfaces by BSA. In previous work we have shown
that the truncated Sph and GlcCer analogues do not perme-
ate membranes but, rather, remain trapped in membrane
vesicles (14, 16) . The same is true for the NBD-sphingolipid
analogues (7). In addition, neither of these lipids is released
from intact cellsduring mitosis (18), nor when they are syn-
thesized at a temperature where vesicular transport to the
plasma membrane is blocked (15°C) . Although at this tem-
perature vesicular transport is blocked in semiintact cells as
well, the t-GlcCer analogue and NBD-GlcCer in the pres-
ence of BSA diffuse out of the cell and are recovered in the
medium . In contrast, the Sph analogues remain in the Golgi.
This indicates that the latter analogues are synthesized in
the Golgi lumen, and GlcCer on the cytosolic side of the or-
ganelle.
GlcCer serves as the precursor for virtually all complex
glycosphingolipids including the gangliosides. First, a galac-
tosyl moiety is added to GlcCer to yield LacCer. This and
the subsequent reactions in the assembly are likely to be
localized in the lumen of the Golgi: cells with a mutation in
the Golgi UDP-Gal carrier can only synthesize GlcCer (9).
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To make GlcCer available for the galactosyl transferase a
carrier must be postulated that would translocate newly syn-
thesized GlcCer from the cytosolic leaflet to the luminal
leaflet of the organelle (11) . In addition, translocation of
GlcCer may be required for its transport to and expression
on the cell surface. It has been observed previously that part
of the t-GlcCer and NBD-GlcCer was Golgi associated un-
der conditions not very different from the present ones (16,
33). We are directing our present efforts at defining the re-
quirementsfor translocation to the Golgilumen and the exact
location of this event. It is unlikely that the translocator is
also present in the plasma membrane. In that case, t-GlcCer
and NBD-GlcCershould have been ableto leave the cell even
in the absence of vesicular transport at low temperature or
in mitotic cells, which is not observed (see above). After
synthesis, endogenous "normal long chain GlcCer cannot
escape the Golgi membrane because its long hydrophobic
chains are tightly embedded into the bilayer. It can therefore
efficiently reach, and be translocated by, the carrier. In con-
trast, the t-GlcCer derivative is not restricted to the bilayer
but in equilibrium with the cytosol and might thus escape
the translocation event. Similarly, NBD-GlcCer will not be
limited to the cytosolic surface of the Golgi but equilibrate
with other intracellular membranes. This was indeed ob-
served aftercell fractionation (Fig. 6B) where NBD-GlcCer
was located in other membranes than the synthesizing ac-
tivity (Fig. 8). Nevertheless, translocation of both GlcCer
analogues is efficient since they are rapidly transported to
the surface of intact cells (16, 20, 33, 35) . This may be
explained by the fact that the volume of the cytosol is rela-
tively small, which would guarantee a significant concentra-
tion of t-GlcCer in the Golgi membrane. A similar argument
applies to the NBD-GlcCer. In semiintact cells, however, the
cytosol can exchange freely with the surrounding medium.
Under this condition t-GlcCer is diluted several hundredfold
while NBD-GlcCer will equilibrate with the excess of scav-
enger BSA in the medium. The analogues will thus have a
correspondingly smaller chance to be translocated into the
lumen of the Golgi. Consequently they will diffuse out of
semiintact cells even at low temperature.
A variety ofGolgi enzymes have been ascribed to different
subsites of the Golgi apparatus. For the analysis of Golgi
subsites we have fractionated the Golgi on sucrose gradients
and followed the activities of N-acetylglucosaminyl-phos-
photransferase (25) and of galactosyltransferase (26), estab-
lished markers of the proximal and the distal Golgi, respec-
tively. Although baseline separation ofthese marker enzyme
activitieswas not achieved, the activity peaksare clearly and
reproducibly shifted fromeach other. The maximal activities
of t-Sph and t-GlcCer synthesis coincide with the proximal
Golgi. For Sph this confirms earlier work (12, 15) . A second
peak of glucosylceramide synthesis activity is clearly and
reproducibly separated and appears at a buoyant density
similar to that of membranes enriched in galactosyltransfer-
ase, a "late Golgi enzyme.
Our finding that part of the GlcCer may be synthesized on
the distal Golgi would contradict the straight forward hy-
pothesis that the sequence of biosynthetic events correlates
with the localization of the enzymes involved, i.e., "early"
enzymes located to the "earlyproximal Golgi, and "late" en-
zymes to the "late" distal Golgibecause the possibility exists
265that the late Golgi compartment displaying GIcCer synthesis
may be distal to the galactosyl-transferase compartment. On
the one hand, GIcCer synthesized there may be accessible
for the postulated carrier protein and translocated to the lu-
minal side, afterwhich it would be transported as GIcCer to
the cell surface. This mechanism would easily explain the
fact that an appreciable part of the glycolipid escapes further
sugar transfer reactions and is expressed at the cell surface
as the monohexosylceramide. On the other hand, it may be
subject to cytosolic transfer by specific proteins (1) and thus
be delivered to those cisternae containing the galactosyl-
transferase. In this way the glucolipid would be available to
higher glycolipid synthesizing compartments according to
need because with a GIcCer carrier the cytoplasmic leaflet
ofthese membranes would become depleted ofthe glucolipid
at the same pace galactosyl transfer occurs in the lumen to
yield lactosylceramide.
The results obtained with CHO cells and both rat and rab-
bit liverGolgi using t-Cer have been reproduced with human
liver derived HepG2 cells and NBD-ceramide, indicating
that our findings are not restricted to a special assay or cell
system. Earlier data (11) and the data presented here together
present strong evidence that glucosylceramide is in fact syn-
thesized at the cytosolic surface of the Golgi apparatus. Lo-
calization studies by sucrose density gradient centrifugation
have revealed different patterns of sphingomyelin and glu-
cosylceramide synthase activities with glucosylceramide
synthase found in both a fraction containing a proximal
Golgi marker and a fraction colocalizing with a distal Golgi
marker. These findings raise a number of questions concern-
ing the intracellular distribution ofGIcCer, the exact location
of its synthesis and of the translocation event. Purification of
the proteins involved and the use of immunoelectron micros-
copy will be required for their precise localization. Unfortu-
nately, we are not aware ofthe existence ofantibodies against
the synthases. Apart from the fact that GIcCer is the most
abundant glycosphingolipid in most cells and that its distri-
bution may be important for the physicochemical properties
of specific membranes or membrane leaflets, it is the precur-
sor for most higher glycosphingolipids including all ganglio-
sides. There is good hope that further work on the synthesis,
translocation, and transport of glucosylceramide will lead to
a better understanding ofthe organization and regulation of
glycosphingolipid expression on the cell surface.
Independent of the present work, similar conclusions on the sidedness of
GIcCer synthesis have been reached by Futerman and Pagano (Futerman,
A. H., and R. E. Pagano. 1991 . Biochem. J. 280:295-302) and by Trin-
chera and colleagues (Trinchera, M ., M. Fabbri, and R. Ghidoni. 1991 .
J. Biol. Chem. 266:20907-20912). Futerman and Pagano furthermore ob-
served that GIcCer synthesis was more widely distributed than the
cis/medial Golgi cistemae and suggested significant synthesis in a pre- or
early Golgi compartment. Trinchera et al . (1991) reported that besides
GIcCer synthesis also the subsequent transfer of galactose to yield lactosyl
ceramide occurred on the cytosolic surface of the Golgi apparatus.
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